MitoQ alleviates triptolide-induced cardiotoxicity via activation of p62/Nrf2 axis in H9c2 cells.

MLA

Tan, Guoyao, et al. “MitoQ Alleviates Triptolide-Induced Cardiotoxicity via Activation of P62/Nrf2 Axis in H9c2 Cells.” Toxicology in Vitro, vol. 86, Feb. 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.tiv.2022.105487.

APA

Tan, G., Qin, Z., Jiang, S., Zhang, L., Zhang, G., Huang, M., Huang, Z., & Jin, J. (2023). MitoQ alleviates triptolide-induced cardiotoxicity via activation of p62/Nrf2 axis in H9c2 cells. Toxicology in Vitro, 86, N.PAG. https://doi.org/10.1016/j.tiv.2022.105487

Chicago

Tan, Guoyao, Zhiyan Qin, Shiqin Jiang, Lei Zhang, Gengyi Zhang, Min Huang, Zhiying Huang, and Jing Jin. 2023. “MitoQ Alleviates Triptolide-Induced Cardiotoxicity via Activation of P62/Nrf2 Axis in H9c2 Cells.” Toxicology in Vitro 86 (February): N.PAG. doi:10.1016/j.tiv.2022.105487.